Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group (Q51581141)
scientific article published in June 1996
Language:
(P31) (Q13442814)
(P50) (Q38320516)
(P304) 701-709
(P433) 6
(P478) 39
(P577) Saturday, June 1, 1996
(P921) (Q7240673)
(P1433) (Q5270140)
(P1476) "Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group" (language: en)
(P2093) S Kumar
A J Boulton
H Beck-Nielsen
F Berthezene
M Muggeo
G A Spinas
S Donoghue
S Lettis
P Stewart-Long
(P2860) (Q51679983)
(Q42446332)
(Q40521981)
(Q67521964)
(Q51595095)
(Q38700011)
(Q72448175)
(Q40619457)
(Q50546299)
(Q51604931)
(Q72662551)
(Q34324049)
(Q51672193)
(Q51590269)
(Q51593626)
(Q46031824)
(Q37742798)
(Q51594406)
(Q51660630)
(Q38346193)
(Q46914156)
(Q51595759)
(Q46090838)
(Q43832606)
(Q29615693)
(Q41486246)
(Q67868236)
(Q39567008)
(Q26776977)
other details
description scientific article published in June 1996

External Links